SGLT2 Inhibitors vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving Metformin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium-Glucose Cotransporter-2 Inhibitors vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving Metformin
JAMA Intern Med 2024 Apr 15;[EPub Ahead of Print], N McCormick, C Yokose, N Lu, DJ Wexler, JA Aviña-Zubieta, MA De Vera, RG McCoy, HK ChoiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.